NEWS COMMENTARY

Alibaba and Ping An develop AI-based diagnostics to detect coronovirus infection from CT scans in seconds

Published:
March 05, 2020
Services:
Consumer
Activities:
Claims More...
Very important

As the coronavirus epidemic becomes a larger global threat, time is of the essence in diagnosing and treating patients. In our recent report, we highlighted how point-of-care diagnostics (POCD) for infectious diseases today still suffer from lack of speed and reliability. Cheek swabs, the primary diagnostic method, employ a PCR-based technique that takes a few hours at best. Alibaba and Ping An have developed an AI-based diagnostic that they claim can detect coronavirus-positive cases with 96% and 90% accuracy within 20 seconds and 15 seconds, respectively, from CT scans. Clients should monitor how these two giants deploy their solutions, especially if thy have interest in partnering to bring these solutions to other markets outside China.

For the original news article, click here .


Further Reading

FDA authorizes emergency use of Lucira's at-home test kit – with results in 30 minutes and no shipping to a lab

News Commentary | November 25, 2020

This advancement in POC testing is one that decentralizes the testing process and allows for nearly immediate self‑quarantine and thereby reducing the burden on shipping and laboratory infrastructure. While clients may want to take note of this development for use for their own employees, clients ... To read more, click here.

Scientists develop a method to detect COVID-19 and its variants simultaneously

News Commentary | May 31, 2021

There are various methods to screen individuals for COVID‑19 today. However, these tests only tell you if you're "positive" or "negative" for COVID‑19. They do not give you details about which variants you may have if you test positive. That requires a further sequencing step to confirm, which may ... Not part of subscription

Human Genomics

Technology | August 25, 2021

The sequencing, analysis, and interpretation of the human genome, which leads to therapeutic, diagnostic, and wellness applications. Not part of subscription